Endovesical treatment as an alternative to BCG for intermediate or high-risk NMI bladder cancer A shortage of BCG is foreseen till the end of 2013. Which will be the management of intermediate and high-risk NMI-BC if BCG will not be available? In patients harboring high-risk NMI tumors, particularly T1G3 and Tis, the first therapeutic choice is radical cystectomy. Device-assisted therapies, although showing promising results, should be considered only for selected patients. In intermediate risk patients, intravesical chemotherapy remains a legitimate option even if BCG is available. Thus, in a period of BCG shortage, intravesical chemotherapy should be offered, preferably preceded by early instillation, according to the EAU guidelines.
Serretta, V., Colombo, R. (2013). Trattamento endovescicale alternativo al BCG nel carcinoma vescicale NMI a rischio intermedio o elevato. UROLOGIA, 80(80 (S21)), 24-26 [10.5301/RU.2013.10860].
Trattamento endovescicale alternativo al BCG nel carcinoma vescicale NMI a rischio intermedio o elevato
SERRETTA, Vincenzo;
2013-01-01
Abstract
Endovesical treatment as an alternative to BCG for intermediate or high-risk NMI bladder cancer A shortage of BCG is foreseen till the end of 2013. Which will be the management of intermediate and high-risk NMI-BC if BCG will not be available? In patients harboring high-risk NMI tumors, particularly T1G3 and Tis, the first therapeutic choice is radical cystectomy. Device-assisted therapies, although showing promising results, should be considered only for selected patients. In intermediate risk patients, intravesical chemotherapy remains a legitimate option even if BCG is available. Thus, in a period of BCG shortage, intravesical chemotherapy should be offered, preferably preceded by early instillation, according to the EAU guidelines.File | Dimensione | Formato | |
---|---|---|---|
Urologia_OQ_2013_26-29.pdf
Solo gestori archvio
Descrizione: articolo
Dimensione
164.51 kB
Formato
Adobe PDF
|
164.51 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.